Status:

UNKNOWN

Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause

Lead Sponsor:

Federal University of São Paulo

Conditions:

Menopause

Eligibility:

FEMALE

45-65 years

Phase:

PHASE3

Brief Summary

Hypoestrogenism, common in menopause, is responsible for systemic and metabolic changes affecting women's wellness, favoring hot flashes, urogenital atrophy and bone mass loss. Hormone reposition ther...

Eligibility Criteria

Inclusion

  • \> 1 year of amenorrhea
  • 45 to 65 years old
  • without hormone reposition treatment or herbal medications in the 6 months preceding the research

Exclusion

  • history of thromboembolism
  • history of cardiovascular disease
  • presence of estrogen dependent neoplasia
  • presence of abnormal genital bleeding
  • uncontrolled metabolic diseases
  • smoking or drinking habits
  • use of anticoagulants or acetyl salicylic acid

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2010

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT00925639

Start Date

August 1 2009

End Date

August 1 2010

Last Update

June 22 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ambulatório de Ginecologia Endócrina

São Paulo, São Paulo, Brazil, 04039-060

Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause | DecenTrialz